Literature DB >> 16896596

Tissue microarrays: applications in urological cancer research.

A S Merseburger1, A G Anastasiadis, J Hennenlotter, D Schilling, P Simon, S A Machtens, J Serth, A Stenzl, M A Kuczyk.   

Abstract

Tissue microarrays (TMAs) are used to simultaneously study the expression of proteins in hundreds of tissue samples, offering the important advantage to screen large tissue banks for biomarker expression and to simultaneously examine serial sections obtained from the same tumor specimen by a time- and cost-effective analytical approach. This review article presents an overview of the importance and the impact of this technique in cancer research with increasing number of investigations using TMAs in its eighth anniversary. Its application, limitations, and selected previous study results regarding urologic malignancies are presented and discussed.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16896596     DOI： 10.1007/s00345-006-0103-1

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


  24 in total

1.  Web-based tissue microarray image data analysis: initial validation testing through prostate cancer Gleason grading.

Authors:  G S Bova; G Parmigiani; J I Epstein; T Wheeler; N R Mucci; M A Rubin
Journal:  Hum Pathol       Date:  2001-04       Impact factor: 3.466

2.  Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma.

Authors:  Harri Visapää; Matthew Bui; Yunda Huang; David Seligson; Henry Tsai; Allan Pantuck; Robert Figlin; Jian Y u Rao; Arie Belldegrun; Steve Horvath; Aarno Palotie
Journal:  Urology       Date:  2003-04       Impact factor: 2.649

3.  Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays.

Authors:  Spyro Mousses; Lukas Bubendorf; Urs Wagner; Galen Hostetter; Juha Kononen; Robert Cornelison; Natalie Goldberger; Abdel G Elkahloun; Niels Willi; Pasi Koivisto; William Ferhle; Mark Raffeld; Guito Sauter; Olli-P Kallioniemi
Journal:  Cancer Res       Date:  2002-03-01       Impact factor: 12.701

4.  High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer.

Authors:  J Richter; U Wagner; J Kononen; A Fijan; J Bruderer; U Schmid; D Ackermann; R Maurer; G Alund; H Knönagel; M Rist; K Wilber; M Anabitarte; F Hering; T Hardmeier; A Schönenberger; R Flury; P Jäger; J L Fehr; P Schraml; H Moch; M J Mihatsch; T Gasser; O P Kallioniemi; G Sauter
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

5.  Ki67, gelsolin and PTEN expression in sarcomatoid renal tumors.

Authors:  Harri Visapää; David Seligson; Yunda Huang; Jian Yu Rao; Arie Belldegrun; Steve Horvath; Aarno Palotie
Journal:  Urol Res       Date:  2002-11-15

6.  ANX7, a candidate tumor suppressor gene for prostate cancer.

Authors:  M Srivastava; L Bubendorf; V Srikantan; L Fossom; L Nolan; M Glasman; X Leighton; W Fehrle; S Pittaluga; M Raffeld; P Koivisto; N Willi; T C Gasser; J Kononen; G Sauter; O P Kallioniemi; S Srivastava; H B Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

7.  Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer.

Authors:  Tobias Zellweger; Christoph Ninck; Martina Mirlacher; Matthias Annefeld; Andrew G Glass; Thomas C Gasser; Michael J Mihatsch; Edward P Gelmann; Lukas Bubendorf
Journal:  Prostate       Date:  2003-04-01       Impact factor: 4.104

8.  P63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors.

Authors:  Cord Langner; Manfred Ratschek; Oleksiy Tsybrovskyy; Luigi Schips; Richard Zigeuner
Journal:  J Histochem Cytochem       Date:  2003-08       Impact factor: 2.479

9.  Expression of neutral amino acid transporter ASCT2 in human prostate.

Authors:  Rile Li; Mamoun Younes; Anna Frolov; Thomas M Wheeler; Peter Scardino; Makoto Ohori; Gustavo Ayala
Journal:  Anticancer Res       Date:  2003 Jul-Aug       Impact factor: 2.480

10.  Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray.

Authors:  Y Hedberg; B Ljungberg; G Roos; G Landberg
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640
View more
  3 in total

1.  Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression?

Authors:  Tilman Todenhöfer; Jörg Hennenlotter; Ursula Kühs; Valentina Gerber; Georgios Gakis; Ulrich Vogel; Stefan Aufderklamm; Axel Merseburger; Judith Knapp; Arnulf Stenzl; Christian Schwentner
Journal:  World J Urol       Date:  2012-03-11       Impact factor: 4.226

2.  Maspin protein expression correlates with tumor progression in non-muscle invasive bladder cancer.

Authors:  Mario W Kramer; Sandra Waalkes; Jörg Hennenlotter; Jürgen Serth; Arnulf Stenzl; Markus A Kuczyk; Axel S Merseburger
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

3.  Tissue microarrays analysis in chondrosarcomas: light microscopy, immunohistochemistry and xenograft study.

Authors:  Isidro Machado; Francisco Giner; Empar Mayordomo; Carmen Carda; Samuel Navarro; Antonio Llombart-Bosch
Journal:  Diagn Pathol       Date:  2008-07-15       Impact factor: 2.644
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.